XORTX Therapeutics, Inc. (XRTX)
0.845
0.00 (0.00%)
USD |
NASDAQ |
Nov 10, 16:00
0.845
0.00 (0.00%)
After-Hours: 16:16
XORTX Therapeutics Price : 0.845 for Nov. 10, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 09, 2026 | 0.9214 | 0.9428 | 0.8401 | 0.845 | 26495.00 |
| Nov 06, 2026 | 0.90 | 0.945 | 0.8603 | 0.91 | 13369.00 |
| Nov 05, 2026 | 0.9411 | 0.9526 | 0.89 | 0.92 | 31597.00 |
| Nov 04, 2026 | 1.01 | 1.03 | 0.98 | 0.99 | 17935.00 |
| Nov 03, 2026 | 1.065 | 1.065 | 1.00 | 1.00 | 5436.00 |
| Nov 02, 2026 | 1.03 | 1.06 | 0.9722 | 1.01 | 12510.00 |
| Oct 30, 2026 | 1.01 | 1.110 | 0.945 | 1.00 | 24986.00 |
| Oct 29, 2026 | 0.98 | 1.15 | 0.952 | 1.03 | 14321.00 |
| Oct 28, 2026 | 1.02 | 1.082 | 1.02 | 1.05 | 11055.00 |
| Oct 27, 2026 | 1.03 | 1.11 | 0.9150 | 1.10 | 39168.00 |
| Oct 26, 2026 | 0.90 | 1.14 | 0.83 | 1.06 | 120713.0 |
| Oct 23, 2026 | 0.95 | 0.95 | 0.915 | 0.9201 | 20233.00 |
| Oct 22, 2026 | 0.9851 | 0.9851 | 0.91 | 0.9688 | 24719.00 |
| Oct 21, 2026 | 0.9687 | 1.05 | 0.9002 | 0.9301 | 72293.00 |
| Oct 20, 2026 | 0.99 | 1.04 | 0.92 | 0.9555 | 87106.00 |
| Oct 19, 2026 | 1.22 | 1.24 | 0.9901 | 1.01 | 130103.0 |
| Oct 16, 2026 | 1.39 | 1.416 | 1.21 | 1.24 | 95826.00 |
| Oct 15, 2026 | 1.53 | 1.54 | 1.41 | 1.42 | 127192.0 |
| Oct 14, 2026 | 1.60 | 1.71 | 1.56 | 1.56 | 79480.00 |
| Oct 13, 2026 | 1.62 | 1.73 | 1.51 | 1.68 | 177604.0 |
| Oct 12, 2026 | 1.40 | 1.90 | 1.39 | 1.72 | 1.761M |
| Oct 09, 2026 | 2.05 | 2.080 | 1.36 | 1.41 | 18.65M |
| Oct 08, 2026 | 1.75 | 1.90 | 1.72 | 1.85 | 10.68M |
| Oct 07, 2026 | 1.73 | 1.75 | 1.69 | 1.745 | 21733.00 |
| Oct 06, 2026 | 1.75 | 1.788 | 1.71 | 1.73 | 40942.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lexaria Bioscience Corp. | 4.70 |
| Mentari Therapeutics, Inc. | 12.22 |
| Target Group, Inc. (Canada) | 0.0008 |
| NervGen Pharma Corp. | 1.34 |
| Milestone Pharmaceuticals, Inc. | 0.6862 |
Price Related Metrics
| PEG Ratio | -0.0067 |
| Price to Book Value | 0.2657 |
| Earnings Yield | -324.8% |
| Market Cap | 1.462M |
| PEGY Ratio | -0.0067 |